This trial is no longer recruiting

Recruitment for this study has ended, so applications are closed. You can still read the trial details, or browse similar trials that are currently recruiting.

Not recruiting

Tendyne Transcatheter

Sponsor:

Abbott Medical Devices

Code:

NCT03433274

Conditions

Mitral Regurgitation

Mitral Insufficiency

Mitral Valve Insufficiency

Cardiovascular Diseases

Valve Disease, Heart

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tendyne Mitral Valve System

MitraClip System

Study Details

Brief summary:

Prospective, controlled, multicenter clinical investigation with four trial cohorts: Randomized, Non-repairable, Severe Mitral Annular Calcification (MAC) and Severe Mitral Annular Calcification Continued Access Protocol (MAC CAP). Subjects in the Randomized cohort will be randomized in a 1:1 ratio to the trial device or to the MitraClip system. Subjects in the Non-repairable, Severe MAC, and Severe MAC CAP cohorts will receive the trial device.

The objective of the Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT) is to evaluate the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System for the treatment of patients with symptomatic, moderate-to-severe or severe mitral regurgitation or for patients with symptomatic mitral valve disease due to severe mitral annular calcification.

This randomized controlled trial will provide the opportunity to evaluate the safety and clinical benefits of the Tendyne Transcatheter Mitral Valve System compared to the MitraClip System in patients with symptomatic, moderate-to-severe or severe mitral regurgitation, within approved MitraClip indications. In addition, the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System will be evaluated in patients with severe mitral annular calcification who are at prohibitive risk for mitral valve surgery. Patients who are not suitable for mitral valve surgery for reasons other than severe mitral annular calcification and are also not suitable for transcatheter repair with MitraClip, will be enrolled in the Non-repairable cohort.

Subjects will be seen at screening, pre- and post-procedure, discharge, 30 days, 3 months, 6 months, and annually through 5 years.

Conditions

Mitral Regurgitation

Mitral Insufficiency

Mitral Valve Insufficiency

Cardiovascular Diseases

Valve Disease, Heart

Study ID

NCT03433274

Start date

Jun 15, 2018

Status verified date

Aug, 2024

Completion date

Jun, 2028

Anticipated

Primary completion date

May 15, 2024

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Symptomatic, moderate-to-severe or severe mitral regurgitation, or severe mitral annular calcification (MAC)
  • NYHA Functional Classification ≥ II (if Class IV, patient must be ambulatory)
  • The local site heart team determines that the subject has been adequately treated per applicable standards
  • Not a member of a vulnerable population

Exclusion Criteria:

  • Mitral valvular vegetation or mass
  • Left ventricular ejection fraction < 25%
  • Left ventricular end diastolic diameter > 7.0 cm
  • Prior surgical or interventional treatment of mitral valve involving implantation of prosthetic material
  • Aortic valve disease requiring surgery or transcatheter intervention
  • Severe tricuspid regurgitation or any tricuspid valve disease requiring surgery or transcatheter intervention
  • Any planned surgical / interventional procedure within 60 day prior to or following subject randomization
  • Subject undergoing hemodialysis due to chronic renal failure
  • Mitral pathoanatomy and left ventricular outflow tract anatomy deemed not suitable for Trial device implantation
  • Subjects with non-cardiac comorbidities that are likely to result in a life expectancy of less than 12 months

Study Design

Enrollment

958 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Randomized Cohort - Treatment Group

Treatment of mitral regurgitation with the Tendyne Transcatheter Mitral Valve System

active comparator: Randomized Cohort - Control Group

Treatment of mitral regurgitation within commercially approved MitraClip system indications

experimental: Non-repairable Cohort

Treatment of mitral regurgitation with the Tendyne Transcatheter Mitral Valve System

experimental: Severe Mitral Annular Calcification (MAC) Cohort

Treatment of mitral regurgitation and mitral annular calcification with the Tendyne Transcatheter Mitral Valve System

experimental: Severe Mitral Annular Calcification Continued Access Protocol (MAC CAP) Cohort

Treatment of mitral regurgitation and mitral annular calcification with the Tendyne Transcatheter Mitral Valve System after the completion of enrollment in the Severe MAC Cohort

Interventions

Tendyne Mitral Valve System

Mitral valve replacement

MitraClip System

Percutaneous mitral valve repair using the MitraClip system.

Primary outcome measure

  • Randomized Cohort [ Time Frame: 1 year ]
  • Non-repairable Cohort [ Time Frame: 1 year ]
  • Severe Mitral Annular Calcification (MAC) Cohort [ Time Frame: 1 year ]
  • Severe MAC Continued Access Protocol (MAC CAP) Cohort [ Time Frame: 1 year ]

Central Contacts and Locations

Locations

UAB University Hospital

Recruiting

Birmingham, Alabama, United States, 35233

Contacts

Principal Investigator:

Mustafa Ahmed, M.D.

Banner-University Medical Center

Recruiting

Phoenix, Arizona, United States, 85006

Contacts

Principal Investigator:

Philip Gideon, M.D.

HonorHealth Scottsdale Shea Medical Center

Recruiting

Scottsdale, Arizona, United States, 85258

Contacts

Principal Investigator:

David Rizik, M.D.

Baptist Health Medical Center

Recruiting

Little Rock, Arkansas, United States, 72205

Contacts

Principal Investigator:

Bassam Shukrallah, MD

University of California - Davis Medical Center

Recruiting

Sacramento, California, United States, 95817

Contacts

Principal Investigator:

Jason Rogers, M.D.

San Diego Cardiac Center

Recruiting

San Diego, California, United States, 92123

Contacts

Principal Investigator:

Raghava Gollapudi, M.D.

Stanford Health Care

Recruiting

Stanford, California, United States, 94305

Contacts

Principal Investigator:

Rahul Sharma, M.D.

Los Robles Hospital and Medical Center

Recruiting

Thousand Oaks, California, United States, 91360

Contacts

Principal Investigator:

Gregory Fontana, M.D.

Morton Plant Hospital

Recruiting

Clearwater, Florida, United States, 33756

Contacts

Principal Investigator:

Joshua Rovin, M.D.

Shands at the University of Florida

Recruiting

Gainesville, Florida, United States, 32610

Contacts

Principal Investigator:

Thomas Beaver, M.D.

Tallahassee Research Institute

Recruiting

Tallahassee, Florida, United States, 32308

Contacts

Principal Investigator:

Thomas Noel, M.D.

Cleveland Clinic Florida

Recruiting

Weston, Florida, United States, 33331

Contacts

Principal Investigator:

Samir Kapadia, M.D.

Piedmont Heart Institute

Recruiting

Atlanta, Georgia, United States, 30309

Contacts

Principal Investigator:

Vinod Thourani, M.D.

Emory University Hospital

Recruiting

Atlanta, Georgia, United States, 30322

Contacts

Principal Investigator:

Vasilis Babaliaros, M.D.

Wellstar Kennestone Hospital

Recruiting

Marietta, Georgia, United States, 30060

Contacts

Principal Investigator:

Amar Patel, MD

Advocate Christ Medical Center

Recruiting

Oak Lawn, Illinois, United States, 60453

Contacts

Principal Investigator:

Ravi Ramana, M.D.

St. Vincent Hospital

Recruiting

Indianapolis, Indiana, United States, 46260

Contacts

Principal Investigator:

Sina Moainie, M.D.

Cardiovascular Research Institute of Kansas

Recruiting

Wichita, Kansas, United States, 67226

Contacts

Principal Investigator:

Bassem Chehab, M.D.

MedStar Health Research Institute

Recruiting

Balitmore, Maryland, United States, 21218

Contacts

Principal Investigator:

Brian Bethea, M.D.

University of Michigan

Recruiting

Ann Arbor, Michigan, United States, 48109

Contacts

Principal Investigator:

Matthew Romano, M.D.

Henry Ford Hospital

Recruiting

Detroit, Michigan, United States, 48202

Contacts

Principal Investigator:

Tiberio Frisoli, M.D.

Abbott Northwestern Hospital

Recruiting

Minneapolis, Minnesota, United States, 55407

Contacts

Principal Investigator:

Paul Sorajja, M.D.

Mayo Clinic

Recruiting

Rochester, Minnesota, United States, 55905

Contacts

Principal Investigator:

Mayra Guerrero, MD

St. Luke's Hospital

Recruiting

Kansas City, Missouri, United States, 64111

Contacts

Principal Investigator:

Keith Allen, M.D.

The International Heart Institute of Montana

Recruiting

Missoula, Montana, United States, 59802

Contacts

Principal Investigator:

James Maddux, M.D.

Hackensack University Medical Center

Recruiting

Hackensack, New Jersey, United States, 07601

Contacts

Principal Investigator:

Ryan Kaple, M.D.

Robert Wood Johnson University Hospital

Recruiting

New Brunswick, New Jersey, United States, 08901

Contacts

Principal Investigator:

Mark Russo, M.D.

Newark Beth Israel Medical Center

Recruiting

Newark, New Jersey, United States, 07112

Contacts

Principal Investigator:

Arash Salemi, M.D.

Albany Medical College at Albany Medical Center

Recruiting

Albany, New York, United States, 12208

Contacts

Principal Investigator:

Sanjay Samy, M.D.

South Shore University Hospital

Recruiting

Bay Shore, New York, United States, 11706

Contacts

Principal Investigator:

Robert Kalimi, M.D.

Buffalo General Hospital

Recruiting

Buffalo, New York, United States, 14203

Contacts

Principal Investigator:

Vijay Iyer, M.D.

New York Presbyterian Hospital/ Weill Cornell Medical Center

Recruiting

New York, New York, United States, 10065

Contacts

Principal Investigator:

Stephanie Mick, M.D.

Lenox Hill Hospital

Recruiting

New York, New York, United States, 10075

Contacts

Principal Investigator:

Robert Kalimi, M.D.

Mission Health & Hospitals

Recruiting

Asheville, North Carolina, United States, 28801

Contacts

Principal Investigator:

Mark Groh, M.D.

Carolinas Medical Center

Recruiting

Charlotte, North Carolina, United States, 28203

Contacts

Principal Investigator:

Michael Rinaldi, M.D.

Novant Health Heart and Vascular Research Institute

Recruiting

Charlotte, North Carolina, United States, 28204

Contacts

Principal Investigator:

Oluseun Alli, M.D.

University of Cincinnati Medical Center

Recruiting

Cincinnati, Ohio, United States, 45219

Contacts

Principal Investigator:

Imran Arif, MD

The Cleveland Clinic Foundation

Recruiting

Cleveland, Ohio, United States, 44195

Contacts

Principal Investigator:

Samir Kapadia, M.D.

Oklahoma Heart Institute at Utica

Recruiting

Tulsa, Oklahoma, United States, 74104

Contacts

Principal Investigator:

Kamran Muhammad, M.D.

Providence Heart & Vascular Institute

Recruiting

Portland, Oregon, United States, 97225

Contacts

Principal Investigator:

Brandon Jones, M.D.

Allegheny General Hospital - ASRI

Recruiting

Pittsburgh, Pennsylvania, United States, 15212

Contacts

Principal Investigator:

Walter McGregor, M.D.

UPMC Shadyside

Recruiting

Pittsburgh, Pennsylvania, United States, 15232

Contacts

Principal Investigator:

Anson Smith, M.D.

Medical University of South Carolina

Recruiting

Charleston, South Carolina, United States, 29425

Contacts

Principal Investigator:

Marc Katz, M.D.

Baptist Memorial Hospital

Recruiting

Memphis, Tennessee, United States, 38120

Contacts

Principal Investigator:

Basil Paulus, M.D.

Centennial Medical Center

Recruiting

Nashville, Tennessee, United States, 37203

Contacts

Principal Investigator:

Sreekumar Subramanian, M.D.

St. Thomas Hospital

Recruiting

Nashville, Tennessee, United States, 37205

Contacts

Principal Investigator:

Evelio Rodriguez, M.D.

Cardiothoracic & Vascular Surgeons

Recruiting

Austin, Texas, United States, 78756

Contacts

Principal Investigator:

Faraz Kerendi, M.D.

Memorial Hermann Hospital

Recruiting

Houston, Texas, United States, 77030

Contacts

Principal Investigator:

Sukhdeep Basra, M.D.

University of Virginia Medical Center

Recruiting

Charlottesville, Virginia, United States, 22908

Contacts

Principal Investigator:

John Saxon, M.D.

Swedish Medical Center - Heart & Vascular

Recruiting

Seattle, Washington, United States, 98122

Contacts

Principal Investigator:

Sameer Gafoor, M.D.

West Virginia University Hospital

Recruiting

Morgantown, West Virginia, United States, 26506

Contacts

Principal Investigator:

Vinay Badhwar, M.D.

More Information

Sponsor

Abbott Medical Devices

Last update posted

Jan 31, 2025

Last verified

Aug, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-19. This information was provided to ClinicalTrials.gov by Abbott Medical Devices on 2025-01-31.